China’s CanSino says no blood clots reported from COVID-19 shot

15-Apr-2021 Intellasia | Reuters | 5:02 AM Print This Post

China’s CanSino Biologics Inc said on Wednesday that no serious blood clot cases related to its COVID-19 vaccine had been reported so far.

The announcement comes amid multiple cases of people being diagnosed with a blood clot after receiving COVID-19 shots made by AstraZeneca and Johnson & Johnson.


Category: China

Print This Post

Leave a Reply

You must be logged in to post a comment.